SYN-TECH Chem. & Pharm. Co., Ltd. (TPEX:1777)
Taiwan · Delayed Price · Currency is TWD 71.70
+0.20 (0.28%)
May 29, 2026, 1:30 PM CST
SYN-TECH Chem. & Pharm. Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,260 | 1,300 | 1,258 | 1,115 | 986.3 | 893.23 | |
Revenue Growth (YoY) | -3.34% | 3.38% | 12.83% | 13.02% | 10.42% | -9.21% |
Cost of Revenue | 814.91 | 849.88 | 770.72 | 705.17 | 618.3 | 601.88 |
Gross Profit | 445.15 | 450.36 | 486.94 | 409.52 | 368 | 291.35 |
Selling, General & Admin | 90.79 | 91.63 | 93.45 | 89.73 | 89.91 | 86.29 |
Research & Development | 40.05 | 38.87 | 42.51 | 37.91 | 39.86 | 36.48 |
Operating Expenses | 130.83 | 130.5 | 136.14 | 127.67 | 129.77 | 122.77 |
Operating Income | 314.32 | 319.86 | 350.8 | 281.85 | 238.23 | 168.59 |
Interest Expense | -1.32 | -1 | -2.14 | -5.74 | -5.92 | -3.39 |
Interest & Investment Income | 18.23 | 16.89 | 20.31 | 29.73 | 16.01 | 2.26 |
Earnings From Equity Investments | - | - | - | 0.7 | -11.59 | -0.73 |
Currency Exchange Gain (Loss) | -8.37 | -8.37 | 42.97 | 2.57 | 89.96 | -18.79 |
Other Non Operating Income (Expenses) | 6.07 | 6.71 | 7.35 | 5.42 | 34.99 | 119.22 |
EBT Excluding Unusual Items | 328.94 | 334.09 | 419.29 | 314.53 | 361.68 | 267.15 |
Gain (Loss) on Sale of Investments | - | - | -0.78 | - | -6.15 | - |
Gain (Loss) on Sale of Assets | -0.3 | -0.3 | -5.48 | -0.77 | -0.3 | -0.73 |
Other Unusual Items | 0.12 | 0.12 | - | - | - | -237.39 |
Pretax Income | 328.76 | 333.92 | 488.24 | 313.77 | 355.24 | 200.23 |
Income Tax Expense | 71.25 | 72.31 | 94.95 | 62.76 | 59.95 | 23.07 |
Net Income | 257.51 | 261.61 | 393.28 | 251.01 | 295.29 | 177.16 |
Net Income to Common | 257.51 | 261.61 | 393.28 | 251.01 | 295.29 | 177.16 |
Net Income Growth | -32.53% | -33.48% | 56.68% | -14.99% | 66.68% | -5.13% |
Shares Outstanding (Basic) | 44 | 45 | 45 | 45 | 45 | 35 |
Shares Outstanding (Diluted) | 44 | 45 | 45 | 45 | 45 | 35 |
Shares Change (YoY) | -2.27% | 0.02% | 0.03% | 0.05% | 26.57% | 17.18% |
EPS (Basic) | 5.91 | 5.87 | 8.82 | 5.63 | 6.62 | 5.03 |
EPS (Diluted) | 5.89 | 5.85 | 8.80 | 5.62 | 6.61 | 5.02 |
EPS Growth | -30.99% | -33.52% | 56.58% | -14.98% | 31.67% | -19.03% |
Free Cash Flow | 431.44 | 501.19 | 408.92 | -175.05 | -38.59 | 24.93 |
Free Cash Flow Per Share | 9.88 | 11.21 | 9.15 | -3.92 | -0.86 | 0.71 |
Dividend Per Share | 4.000 | 4.000 | 5.300 | 3.500 | 3.000 | 2.150 |
Dividend Growth | -24.53% | -24.53% | 51.43% | 16.67% | 39.53% | -46.25% |
Gross Margin | 35.33% | 34.64% | 38.72% | 36.74% | 37.31% | 32.62% |
Operating Margin | 24.95% | 24.60% | 27.89% | 25.29% | 24.15% | 18.87% |
Profit Margin | 20.44% | 20.12% | 31.27% | 22.52% | 29.94% | 19.83% |
Free Cash Flow Margin | 34.24% | 38.55% | 32.51% | -15.70% | -3.91% | 2.79% |
EBITDA | 457.7 | 463.83 | 491.55 | 390.36 | 316.24 | 237.6 |
EBITDA Margin | 36.32% | 35.67% | 39.09% | 35.02% | 32.06% | 26.60% |
D&A For EBITDA | 143.38 | 143.97 | 140.75 | 108.51 | 78.01 | 69.01 |
EBIT | 314.32 | 319.86 | 350.8 | 281.85 | 238.23 | 168.59 |
EBIT Margin | 24.95% | 24.60% | 27.89% | 25.29% | 24.15% | 18.87% |
Effective Tax Rate | 21.67% | 21.65% | 19.45% | 20.00% | 16.88% | 11.52% |
Advertising Expenses | - | 2.16 | - | - | - | - |